Cited 2 times in
Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도영 | - |
dc.contributor.author | 김범경 | - |
dc.contributor.author | 김승업 | - |
dc.contributor.author | 김은혜 | - |
dc.date.accessioned | 2014-12-18T08:46:18Z | - |
dc.date.available | 2014-12-18T08:46:18Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0954-691X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/86922 | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Antineoplastic Agents/administration & dosage* | - |
dc.subject.MESH | Carcinoma, Hepatocellular/therapy* | - |
dc.subject.MESH | Drug Administration Schedule | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms/therapy* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Niacinamide/administration & dosage | - |
dc.subject.MESH | Niacinamide/analogs & derivatives* | - |
dc.subject.MESH | Phenylurea Compounds/administration & dosage* | - |
dc.subject.MESH | Radiotherapy, Adjuvant | - |
dc.subject.MESH | Yttrium Radioisotopes/therapeutic use | - |
dc.title | Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Kim, Eun Hye | - |
dc.contributor.googleauthor | Kim, Beom Kyung | - |
dc.contributor.googleauthor | Kim, Do Young | - |
dc.contributor.googleauthor | Kim, Seung Up | - |
dc.identifier.doi | 10.1097/MEG.0b013e32835c04dd | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00487 | - |
dc.contributor.localId | A00654 | - |
dc.contributor.localId | A00827 | - |
dc.contributor.localId | A00385 | - |
dc.relation.journalcode | J00821 | - |
dc.identifier.eissn | 1473-5687 | - |
dc.identifier.pmid | 23466449 | - |
dc.identifier.url | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00042737-201304000-00020&LSLINK=80&D=ovft | - |
dc.subject.keyword | Antineoplastic Agents/administration & dosage* | - |
dc.subject.keyword | Carcinoma, Hepatocellular/therapy* | - |
dc.subject.keyword | Drug Administration Schedule | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Liver Neoplasms/therapy* | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Niacinamide/administration & dosage | - |
dc.subject.keyword | Niacinamide/analogs & derivatives* | - |
dc.subject.keyword | Phenylurea Compounds/administration & dosage* | - |
dc.subject.keyword | Radiotherapy, Adjuvant | - |
dc.subject.keyword | Yttrium Radioisotopes/therapeutic use | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.alternativeName | Kim, Beom Kyung | - |
dc.contributor.alternativeName | Kim, Seung Up | - |
dc.contributor.alternativeName | Kim, Eun Hye | - |
dc.contributor.affiliatedAuthor | Kim, Beom Kyung | - |
dc.contributor.affiliatedAuthor | Kim, Seung Up | - |
dc.contributor.affiliatedAuthor | Kim, Eun Hye | - |
dc.contributor.affiliatedAuthor | Kim, Do Young | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 25 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 514 | - |
dc.citation.endPage | 515 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, Vol.25(4) : 514-515, 2013 | - |
dc.identifier.rimsid | 32035 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.